Journal
VACCINE
Volume 27, Issue 52, Pages 7402-7408Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2009.08.089
Keywords
Live vaccine; H5N1; Non-pathogenic influenza virus library
Categories
Funding
- Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases
- MEXT Japan
Ask authors/readers for more resources
Outbreaks of highly pathogenic avian influenza viruses (HPAIVs) would cause disasters worldwide. Various strategies against HPAIVs are required to control damage. it is thought that the use of non-pathogenic avian influenza viruses as live vaccines will be effective in an emergency, even though there might be some adverse effects, because small amounts of live vaccines will confer immunity to protect against HPAIV infection. Therefore, live vaccines have the advantage of being able to be distributed worldwide soon after an outbreak. In the present study, we found that intranasal administration of a live H5N1 subtype non-pathogenic virus induced antibody and cytotoxic T lymphocyte responses and protected mice against H5N1 HPAIV infection. In addition, it was found that a small amount (100 PFU) of the live vaccine was as effective as 100 mu g (approximately 10(10-11) PFU of virus particles)of the inactivated whole particle vaccine in mice. Consequently, the use of live virus vaccines might be one strategy for preventing pandemics of HPAIVs in an emergency. (C) 2009 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available